Home » Original Article » Private Practice Infectious Disease: Metro Infectious Disease Consultants
- December 31, 2023
Private Practice Infectious Disease: Metro Infectious Disease Consultants
Russell Petrak, M.D.
Metro Infectious Disease Consultants, Burr Ridge, IL 60527, USA
Contact Russell Petrak, M.D.
You can also search for this author inPubMed | Google Scholar |
Robert Fliegelman, D.O.
Metro Infectious Disease Consultants, Burr Ridge, IL 60527, USA
You can also search for this author inPubMed | Google Scholar |
Nicholas Van Hise, Pharm.D.
Metro Infectious Disease Consultants, Burr Ridge, IL 60527, USA
You can also search for this author inPubMed | Google Scholar |
Vishnu Chundi, M.D.
Metro Infectious Disease Consultants, Burr Ridge, IL 60527, USA
You can also search for this author inPubMed | Google Scholar |
Vishal Didwania, M.D.
Metro Infectious Disease Consultants, Burr Ridge, IL 60527, USA
You can also search for this author inPubMed | Google Scholar |
Alice Han, M.D.
Metro Infectious Disease Consultants, Burr Ridge, IL 60527, USA
You can also search for this author inPubMed | Google Scholar |
Brian Harting, M.D.
Metro Infectious Disease Consultants, Burr Ridge, IL 60527, USA
You can also search for this author inPubMed | Google Scholar |
Tiffany Killblane
Metro Infectious Disease Consultants
Contact Tiffany Killblane
You can also search for this author inPubMed | Google Scholar |
Elizabeth Ablah
Metro Infectious Disease Consultants
Contact Elizabeth Ablah
You can also search for this author inPubMed | Google Scholar |
Hayrettin Okut
Metro Infectious Disease Consultants
Contact Hayrettin Okut
You can also search for this author inPubMed | Google Scholar |
Lauren Bricker
Metro Infectious Disease Consultants
Contact Lauren Bricker
You can also search for this author inPubMed | Google Scholar |
Maha Assi
Metro Infectious Disease Consultants
Contact Maha Assi
You can also search for this author inPubMed | Google Scholar |
How to Cite: Petrak, R.; Fliegelman, R.; Van Hise, N.; Chundi, V.; Didwania, V.; Han, A.; Harting, B. Private Practice Infectious Disease: Metro Infectious Disease Consultants. Priv. Pract. Infect. Dis., 2023, 3(4): 9; doi.org/10.55636/ppid3040009.
© 2023 Copyright by Authors. Licensed as an open access article using a CC BY 4.0 license.
METRICS
Keywords: Infectious disease; Compensation; Private Practice
Introduction
The practice of infectious disease (ID) is the most dynamic, stimulating, and challenging subspecialty in medicine. It interfaces with virtually every other medical and surgical specialty, allowing for a diverse patient experience. Hospitals rely on ID physicians to direct antibiotic stewardship and infection
control programs, as well as therapeutic guideline development. Despite extensive efforts by the Infectious Disease Society of America (IDSA), these realities have not been imprinted on the medical workforce in training. Over the last 11 years [1], ID fellowships have failed to fill open positions.
Surveys have consistently listed ID as one of the lowest-paid specialties with one of the highest rates of burnout—a non-sustainable situation [1–4]. The prosperity, lifestyle options, and overall satisfaction with the clinical practice of infectious disease has, unfortunately, been lost in this morass. In an attempt to identify unknown issues, Metro Infectious Disease Consultants (MIDC) conducted an internal physician audit.
MIDC Overview
MIDC comprises 106 infectious disease physicians working in 26 offices, 110 hospitals, and 8 states. Physicians are stratified into four levels: employee, partner, senior partner, and founding partner. Of the 106 ID physicians, 63 are male and 43 are female. Ages range from 31 to 70, with a median age of 46.
Multiple schedules are available for employees, including full- or part-time, and 7 days of consecutive work followed by 7 days off (7/7). In addition, MIDC employs 190 physician extenders.
These professionals are primarily utilized in the inpatient setting to clinically support a larger or more challenging patient population. This results in a more organized workflow, limiting the inherent inefficiencies of hospital care. Physician extenders are also invaluable in the outpatient arena for infusion therapy administration and management. In addition, the supervising physician has the opportunity to provide educational support for the extender.
One hundred and eighty-three nurses provide support for in-office patient care, outpatient parenteral antibiotic therapy (OPAT) evaluation, and infusion administration. Sixteen pharmacists are utilized for antimicrobial stewardship, clinical research, continuing medical education (CME) support, and medication safety.
Having achieved Accreditation Council for Continuing Medical Education certification in 2017, MIDC awarded over 1500 h of category 1 infectious disease CME to their physicians in 2022 alone. With the onset of the pandemic, MIDC convened a weekly meeting available via teleconference. This expedited the transmission of rapidly changing information to the physician, extender, and pharmacy workforce. In addition, these educational events enhanced collegiality and solidified MIDCs efforts to manage these critically ill patients.
MIDC revenue generation is diverse, including inpatient and outpatient consultations, OPAT, biologic infusion supervision, and clinical research. MIDC also services numerous contracts for infection control, antibiotic stewardship, and medical leadership.
Methods
An anonymous audit was sent via email to MIDC physicians. The audit did not include the founding partners, physicians who had joined the group less than 6 months prior, and any physicians whose status had changed in the last 6 months. The evaluation included the degree of satisfaction stratified as very satisfied, satisfied, neutral, dissatisfied, and very dissatisfied.
Satisfaction was further analyzed by the region in which the physician worked, employee or partner, type of work schedule, average number of patients seen, and average number of hospitals serviced per day. In addition, physicians were asked which aspects of the group resulted in the highest job fulfillment. Lastly, an internal financial evaluation was conducted by reviewing the total compensation for each physician and comparing this to the Medscape 2022 and the IDSA 2017 surveys.
The audit was sent to 70 physicians and was completed by 67 (95.7%). Of the 67 respondents, 25 were employees and 42 were partners. Overall, 32 (48%) physicians were very satisfied, 28 (41%) were satisfied, 5 (8%) were neutral, and 2 (3%) were dissatisfied. In total, 22 (52%) partners were very satisfied, 18 (42%) were satisfied, 1 (2%) was neutral, and 1 (2%) was dissatisfied. Ten (40%) employees were very satisfied, 10 (40%) were satisfied, 4 (16%) were neutral, and 1 (4%) was dissatisfied. Of the physicians working full-time, 29 (52%) were very satisfied, 22 (39%) were satisfied, 3 (5%) were neutral, and 2 (4%) were dissatisfied. In total, 2 (33%) part-time employees were very satisfied and 4 (67%) were satisfied. Finally, 1 (20%) of the employees working the 7/7 schedule was very satisfied, 2 (40%) were satisfied, and 2 (40%) were neutral.
The most valuable aspects resulting in job fulfillment varied slightly between partner and employed MIDC physicians. The four most valuable aspects for partners were financial stability (37 (88%)), group collegiality (33 (79%)), nursing/pharmacy support (27 (64%)), and infrastructure support (24 (57%)). Employees valued infrastructure support (22 (88%)), financial stability (19 (76%)), nursing/pharmacy support (16 (64%)), and lifestyle flexibility (16 (64%)).
In total, 71% of physicians serviced one hospital per day, while 21% serviced two, 6% serviced three, and 2% more than three. In terms of patients, 77% of physicians saw less than 25 patients per day, and 36% saw less than 20.
The average yearly remuneration for MIDC employees was 307 thousand, while MIDC partners earned an average of 610 thousand dollars annually.
Analysis
MIDC physicians are highly compensated compared to other ID physicians based on other available surveys [2–4]. A Medscape survey in 2022 listed the yearly average for all ID physicians as 260 thousand dollars. The IDSA 2017 survey showed private practice ID physicians earning an average of 316 thousand dollars yearly. In contrast, the employed physicians of MIDC receive a total remuneration almost identical to the average of all private practice ID physicians. MIDC partners receive an average remuneration that is 93% higher than the average listed for private practice ID physicians in the same IDSA survey [2]. It is unclear to what extent private practice IDs are represented in the Medscape and IDSA surveys. This may have negatively skewed the physician revenue figures.
In addition, 90% of MIDC physicians audited are satisfied or very satisfied. While the interpretation of this satisfaction may be complex, the listing of valuable MIDC aspects would suggest that financial stability is a key factor. ID conversations that deal with the value of infectious disease frequently discuss the ability to direct patient care, interface with multiple factions of a hospital and medical staff, and cost containment efforts. While these are noble and definitive skills, they are not well reimbursed or financially valued. MIDC optimizes reimbursement through a diversification of revenue, which includes, but is not limited to, patient consultation. This provides a safety net as federal payers continue to implement payment cuts over the next several years. These factors, in turn, lead to MIDCs salary numbers being dramatically higher for both employees and partners. The Medscape survey listed the average yearly salary for an ID physician as 260 thousand dollars. In contrast, MIDC employees averaged 18% higher and partners 235% higher than those published numbers.
The ability to incorporate flexible work schedules, such as 7/7 and part-time models, is attractive to a large segment of the ID workforce—both men and women. Utilizing these models to accommodate work–life balance has and should continue to assist in recruiting and retaining clinicians. MIDC-employed physicians highly value this flexibility, as it helps them accommodate to personal stresses while maintaining a professional career.
Clearly, MIDC values physician extenders and incorporates their skills widely. The utilization of extenders results in a clinicians ability to service more patients while spending less time documenting the encounters. Physicians have the opportunity to continue to educate the extender and generate close working relationships, resulting in enhanced efficiencies of care. This frequently translates to increased productivity and time for either professional development or personal endeavors.
As life-long learners, education is an anchor tenant for any ID practice, regardless of model, location, or size. In an environment where private practice ID physicians are not typically associated with progressive education, MIDC has invested significant time and money to refute this belief. MIDC utilizes ACCME certification to provide timely and pertinent infectious disease education to its physicians.
These data may not be generalizable to a large segment of the private practice ID groups. The basic tenets of group productivity and stability, however, should be similar. Revenue diversification (professional fees, OPAT, contracts) generates financial stability, which subsequently establishes a means to attain physician capacity or infrastructure growth. This, in turn, allows for a more comfortable and sustainable clinical practice.
In short, MIDC is organized to optimize patient care by providing a strong clinical workforce surrounded by a robust infrastructure and financial stability. This, combined with lifestyle flexibility, allows for a diverse and collegial atmosphere that is adaptable to the vast majority of infectious disease clinicians.
Author Contributions
Conceptualization, R.P., R.F., N.V.H.; Original draft preparation, R.P.; Review and editing, R.P., R.F., N.V.H., V.C., V.D., A.H., B.H. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Reece, R.; Beckwith, C.G. The Infectious Diseases Specialist, At Risk of Extinction. J. Infect. Dis. 2023, jiad160. [CrossRef] [PubMed]
- McKenna, J. Medscape Infectious Disease Physician Compensation Report 2022: Incomes Gain, Pay Gaps Remain. Medscape. Published. 13 May 2022. Available online: https://www.medscape.com/slideshow/2022-compensation-infectious-disease-6015143 (accessed on 20 April 2023).
- Trotman, R.; Kim, A.I.; MacIntyre, A.T.; Ritter, J. T.; Malani, A.N. 2017 Infectious Diseases Society of America Physician Compensation Survey: Results and Analysis. Open Forum Infect. Dis. 2018, 5, ofy309. [CrossRef] [PubMed]
- Kim, A.; Novinson, D. Battered by Inflation, Physician Pay Isnt What It Once Was. Doximity. Published. 2 May 2023. Available online: https://opmed.doximity.com/articles/battered-byinflation-physician-pay-isn-t-what-it-once-was#:~:text=Physician%20pay%20growth%20has%20lagged,more%20than%20190%2C000%20U.S.%20physicians (accessed on 2 June 2023).